Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 3, 2002, Pages 777-784

  Chappell, Lucy C ^a   Seed, Paul T ^a   Kelly, Frank J ^b   Briley, Annette ^a   Hunt, Beverley J ^b   Charnock Jones, D Stephen ^c   Mallet, Anthony ^d   Poston, Lucilla ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Antioxidant; Oxidative stress; Placenta; Preeclampsia; Pregnancy

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PLACENTA DISORDER; PLACENTA FUNCTION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 0036739012     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.125735     Document Type: Article

References (25)

1. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-35.
2. Sikkema JM, van Rijn BB, Franx A, Bruinse HW, de Roos R, Stroes ESG, et al. Placental superoxide in increased in preeclampsia. Placenta 2001;22:304-8.
3. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Invest 1996; 3:179-84.
4. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy. Clin Sci 1996;91:711-8.
5. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
6. Chappell LC, Seed PT, Briley AL, Kelly KJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354:810-6.
7. Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 1993;100:370-4.
8. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, et al. A longitudinal study of biochemical variables in women at risk of pre-eclampsia. Am J Obstet Gynecol. In press.
9. Roberts LJ, Morrow JD. Measurement of F(2) isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-13.
10. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996;174:288-91.
11. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994;36:487-93.
12. Kelly FJ, Rodgers W, Handel J, Smith S, Hall MA. Time course of vitamin E repletion in the premature infant. Br J Nutr 1990;63:631-8.
13. Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard EE. Analysis of F2 isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B 1995;667:199-208.
14. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
15. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992;11:1685-704.
16. Basu TK, Schorah CJ. Vitamin C in health and disease. Westport (CT): AVI Publishing; 1982. p. 95-100.
17. Regan CL, Levine RJ, Baird DB, Ewekk MG, Martz KL, Sibai BM, et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001;185:572-8.
18. Salonen JT, Nyyssonen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000;248:377-86.
19. Sattar N, Greer IA, Galloway PJ, Packard CJ, Shepherd J, Kelly T, et al. Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 1999;84:128-30.
20. Highman TJ, FriedmanJE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998;178:1010-5.
21. Ashworth CJ, Hoggard N, Thomas L, Mercer JG, Wallace JM, Lea RG. Placental leptin. Rev Reprod 2000;5:18-24.
22. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, et al. Augmented placental production of leptin in pre-eclampsia: possible involvement of hypoxia. J Clin Endocrinol Metab 1998;83:3225-9.
23. Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000; 15:2003-6.
24. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gynaecol 1994;101:488-92.
25. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267-72.